Cargando…

Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach

Inflammation is one of the key processes in the pathogenesis of atherosclerosis. Numerous studies are focused on the local inflammatory processes associated with atherosclerotic plaque initiation and progression. However, changes in the activation state of circulating monocytes, the main components...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikiforov, Nikita G., Wetzker, Reinhard, Kubekina, Marina V., Petukhova, Anna V., Kirichenko, Tatiana V., Orekhov, Alexander N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610245/
https://www.ncbi.nlm.nih.gov/pubmed/31316385
http://dx.doi.org/10.3389/fphar.2019.00725
_version_ 1783432468899037184
author Nikiforov, Nikita G.
Wetzker, Reinhard
Kubekina, Marina V.
Petukhova, Anna V.
Kirichenko, Tatiana V.
Orekhov, Alexander N.
author_facet Nikiforov, Nikita G.
Wetzker, Reinhard
Kubekina, Marina V.
Petukhova, Anna V.
Kirichenko, Tatiana V.
Orekhov, Alexander N.
author_sort Nikiforov, Nikita G.
collection PubMed
description Inflammation is one of the key processes in the pathogenesis of atherosclerosis. Numerous studies are focused on the local inflammatory processes associated with atherosclerotic plaque initiation and progression. However, changes in the activation state of circulating monocytes, the main components of the innate immunity, may precede the local events. In this article, we discuss tolerance, which results in decreased ability of monocytes to be activated by pathogens and other stimuli, and training, the ability of monocyte to potentiate the response to pathological stimuli, and their relation to atherosclerosis. We also present previously unpublished results of the experiments that our group performed with monocytes/macrophages isolated from atherosclerosis patients. Our data allow assuming the existence of relationship between the formation of monocyte training and the degree of atherosclerosis progression. The suppression of trained immunity ex vivo seems to be a perspective model for searching anti-atherogenic drugs.
format Online
Article
Text
id pubmed-6610245
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66102452019-07-17 Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach Nikiforov, Nikita G. Wetzker, Reinhard Kubekina, Marina V. Petukhova, Anna V. Kirichenko, Tatiana V. Orekhov, Alexander N. Front Pharmacol Pharmacology Inflammation is one of the key processes in the pathogenesis of atherosclerosis. Numerous studies are focused on the local inflammatory processes associated with atherosclerotic plaque initiation and progression. However, changes in the activation state of circulating monocytes, the main components of the innate immunity, may precede the local events. In this article, we discuss tolerance, which results in decreased ability of monocytes to be activated by pathogens and other stimuli, and training, the ability of monocyte to potentiate the response to pathological stimuli, and their relation to atherosclerosis. We also present previously unpublished results of the experiments that our group performed with monocytes/macrophages isolated from atherosclerosis patients. Our data allow assuming the existence of relationship between the formation of monocyte training and the degree of atherosclerosis progression. The suppression of trained immunity ex vivo seems to be a perspective model for searching anti-atherogenic drugs. Frontiers Media S.A. 2019-06-27 /pmc/articles/PMC6610245/ /pubmed/31316385 http://dx.doi.org/10.3389/fphar.2019.00725 Text en Copyright © 2019 Nikiforov, Wetzker, Kubekina, Petukhova, Kirichenko and Orekhov http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Nikiforov, Nikita G.
Wetzker, Reinhard
Kubekina, Marina V.
Petukhova, Anna V.
Kirichenko, Tatiana V.
Orekhov, Alexander N.
Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach
title Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach
title_full Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach
title_fullStr Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach
title_full_unstemmed Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach
title_short Trained Circulating Monocytes in Atherosclerosis: Ex Vivo Model Approach
title_sort trained circulating monocytes in atherosclerosis: ex vivo model approach
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610245/
https://www.ncbi.nlm.nih.gov/pubmed/31316385
http://dx.doi.org/10.3389/fphar.2019.00725
work_keys_str_mv AT nikiforovnikitag trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach
AT wetzkerreinhard trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach
AT kubekinamarinav trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach
AT petukhovaannav trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach
AT kirichenkotatianav trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach
AT orekhovalexandern trainedcirculatingmonocytesinatherosclerosisexvivomodelapproach